About
Novel small molecule compounds for demyelinating and inflammatory diseases
Areas of Focus
Categories
Small Molecule PharmaceuticalSouthwestern U.S.
Funding History (1)
D
Aug 28, 2025
Locations (1)
Headquarters
Oklahoma City, OK, United States
Map
Loading map...